TherapeuticsMD (TXMD) Announces $7M Private Placement of Preferred Stock

TherapeuticsMD (NASDAQ: TXMD) announced today that it received an additional $7 million private investment in the Company’s Series A Preferred Stock from Rubric Capital Management LP. TherapeuticsMD expects to use the proceeds from the transaction for working capital.

Under the terms of the Company’s financing agreement with its lender, Sixth Street Specialty Lending, Inc. (“Sixth Street”), upon receipt of the investment and the delivery to Sixth Street of warrants to acquire 125,000 shares of the Company’s common stock at an exercise price of $0.01 per share, the maturity date of the financing agreement was automatically extended until November 30, 2022.

The Company's Board of Directors and management team continue to actively assess strategic alternatives to strengthen the Company’s long-term financial position.

You May Also Be Interested In

• Rocky Shore Gold raises C$3.2M in first tranche of private placement
• Goldcana closes C$2M private placement, issues 8M units
• WISeKey reveals Class B share election results ahead of merger